Yamada Hiroshi | Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
スポンサーリンク
概要
- Yamada Hiroshiの詳細を見る
- 同名の論文著者
- Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratoriesの論文著者
関連著者
-
Yamada Hiroshi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Horii I
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Horii Ikuo
Showa Univ. (department Of Biochemical Toxicology School Of Pharmaceutical Sciences)
-
Horii Ikuo
Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Yamada Hiroshi
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Horii Ikuo
Worldwide Safety Sciences
-
HORII Ikuo
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
Yamada Hiroshi
worldwide safety sciences
-
HAMADA Yoshimasa
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
Kikkawa Rie
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Kikkawa Rie
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kikkawa Rie
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Yamamoto Toshinori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Yamamoto T
Showa Univ. Tokyo Jpn
-
Yamamoto Toshinori
Department Of Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Yamamoto Toshinori
Departments Of Clinical Pharmacy And Pharmacognosy School Of Pharmaceutical Sciences Showa Universit
-
Yamamoto Toshinori
Department Of Pharmacology Medical College Of Oita
-
KIKKAWA Rie
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Fukushima Tamio
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
-
Fukushima Tamio
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Fukushima Tamio
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
YAMAMOTO Toshinori
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Hamada Y.
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Abe Junko
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Harada Takuma
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Harada Takuma
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Shiotani Motohiro
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Abe Junko
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Shitoni Motohiro
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
FUKUSHIMA Tamio
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Fukushima Tamio
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Fujikawa Masaaki
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Shiotani Motohiro
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Fujikawa Masaaki
worldwide safety sciences
-
SHIOTANI Motohiro
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
HARADA Takuma
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
ABE Junko
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
Fujikawa Masaaki
World Wide Safety Sciences
-
Shirai Maki
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Mori C
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Mori Chisato
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Mori Chisato
千葉大学 医学研究院環境生命医学
-
Mori Chisato
Department Of Anatomy Faculty Of Medicine Kyoto University
-
Komiyama M
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Moria Chisato
Department Of Bioenvironmental Medicine:environmental Health Science Project For Future Generations
-
Mori Chisato
Department Of Anatomy And Developmental Biology
-
Tomizawa Kaori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
MORI Chisato
Deparment of Bioenvironmental Medicine, Graduate School of Medicine, Chiba University
-
HORII IKUO
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
Shirai Maki
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
KOMIYAMA Masatoshi
Department of Bioenvironmental Medline, Chiba Univ.
-
IDEGAMI Keiichi
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Idegami Keiichi
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Komiyama Masatoshi
Department Of Bioenvironmental Medicine:center For Environment Health And Field Sciences Chiba Unive
-
Komiyama Masatoshi
Department Of Anatomy And Cell Biology School Of Medicine Chiba Unversity
-
Xu C‐n
National Inst. Advanced Industrial Sci. And Technol. (aist) Tosu
-
Xu Chao-nan
National Institute Of Advanced Industrial Science And Technology
-
Xu Chao-nan
Kyushu National Industrial Research Institute Agency Of Industrial Science And Technology Ministry O
-
Komiyama Masatoshi
Department Of Bioenvironmental Medicine
-
Xu C‐n
National Institute Of Advanced Industrial Science And Technology
-
Wang X
Functional Materials Research Laboratory Tongji University
-
Horii Ikuo
Drug Safety Evaluation Pfizer Global Research And Development
-
Horii Ikuo
Drug Safety Evaluation Global Research & Development Pfizer Inc.
-
Zhou Yu
worldwide safety sciences
-
FUKUSHIMA Tamio
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
HAMADA Yoshimasa
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
YAMADA Hiroshi
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
TOMIZAWA Kaori
Worldwide Safety Sciences
-
HASHIMOTO Keitaro
Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, Universit
-
Idegami Keiichi
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Xu Chao-nan
Presto Japan Science And Technology Agency
-
YAMADA Hiroshi
PRESTO, Japan Science and Technology, Corporation (JST)
-
WANG Xusheng
PRESTO, Japan Science and Technology, Corporation (JST)
-
Horimoto Masao
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Sato Yasushi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Hamada Yoshimasa
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
-
HASHIMOTO Keitaro
Department of Phamacology, Yamanashi Medical University
-
SUZUKI Koji
Department of Public Health, Fujita Health University School of Health Sciences
-
YAMADA Hiroshi
National Insitute for Fusion Science
-
IIDAKA Takeshi
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
Iidaka Takeshi
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Aoyama Hideyuki
Pharmacutical Sciences Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Sakimura Masanori
worldwide safety sciences
-
HORII Ikuo
Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
TOMIZAWA Kaori
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
FUJIKAWA Masaaki
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
SATO Yasushi
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
KIKKAWA Rie
Drug Safety Research & Development, Nagoya Laboratories, Pfizer Japan Inc.
-
SUGANO Kiyohiko
Worldwide Pharmaceutical Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer
-
Sato Yasushi
Worldwide Safety Sciences, PGRD Nagoya Laboratories, Pfizer Inc.
-
Shiotani Motohiro
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
Harada Takuma
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
Abe Junko
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
Hamada Yoshimasa
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
Horii Ikuo
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
SAWADA Yasufusa
Pharmacokinetics Dynamics Metabolism, Pfizer Global Research and Development, Nagoya Laboratories, P
-
Sakai Takanori
World wide safety sciences
-
Iwasaki Kazuhide
Pharmacokinetics Dynamics Metabolism Pfizer Japan Inc
-
KUNIHARA Mineo
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Sakimura Masanori
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kunihara Mineo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
YAO Xi
Functional Materials Research Laboratory, Tongji University
-
Adachi T
Department Of Genomic Drug Discovery Science Graduate School Of Pharmaceutical Sciences Kyoto Univer
-
NISHIKUBO Keiko
National Institute of Advanced Industrial Science and Technology (AIST)
-
Zhou Yu
Woldwide Safety Sciences, Nagoya Laboratories, Pfizer Inc.
-
Shirai Maki
Woldwide Safety Sciences, Nagoya Laboratories, Pfizer Inc.
-
Yamada Hiroshi
Woldwide Safety Sciences, Nagoya Laboratories, Pfizer Inc.
-
Horii Ikuo
Woldwide Safety Sciences, Nagoya Laboratories, Pfizer Inc.
-
Adachi T
Laboratory Of Metabolism Kyoto University Graduate School Of Human And Environmental Studies
-
Kato Masashi
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
Isogai Yumi
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
KIkkawa Rie
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
Hamada Yoshimasa
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
Horimoto Masao
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
KATO MASASHI
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
HORIMOTO MASAO
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
ADACHI TETSUYA
Research Institute for Advanced Science and Technology, Osaka Prefecture University
-
MAKO Tomomi
Worldwide Safety Sciences, Global Research & Development Nagoya Laboratories, Pfizer Japan Inc.
-
HAMADA YOSHIMASA
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
HORII IKUO
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
SHIOTANI Motohiro
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
HARADA Takuma
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
ABE Junko
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
Mako Tomomi
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Mako Tomomi
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Yamamoto Toshinori
Investigative Toxicology & Pathology, Safety Sciences, Pfizer Global Research and Development, Nagoy
-
Kiba Akie
Investigative Toxicology & Pathology, Safety Sciences, Pfizer Global Research and Development, Nagoy
-
Yamada Hiroshi
Investigative Toxicology & Pathology, Safety Sciences, Pfizer Global Research and Development, Nagoy
-
Horii Ikuo
Investigative Toxicology & Pathology, Safety Sciences, Pfizer Global Research and Development, Nagoy
-
Suzuki Koji
Department Of Public Health Fujita Health University Of Health Sciences
-
Sugano Kiyohiko
Worldwide Pharmaceutical Sciences Pfizer Global Research & Development Nagoya Laboratories Pfize
-
Kiba Akie
Investigative Toxicology & Pathology Safety Sciences Pfizer Global Research And Development Nago
-
Isogai Yumi
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Kato M
Safety Study Department Nihon Bioresearch Inc.
-
Zhang Jun-cheng
Functional Materials Research Laboratory Tongji University
-
Kato Masashi
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
WANG Xusheng
Functional Materials Research Laboratory, Tongji University
-
Yao Xi
Functional Materials Research Laboratory Tongji University
-
Yamamoto Toshinori
Drug Metabolism Laboratory Chugai Pharmaceutical Co. Ltd.
-
Nishikubo Keiko
National Institute Of Advanced Industrial Science And Technology
-
SHITONI Motohiro
Worldwide Safety Sciences, Global Research & Development Nagoya Laboratories, Pfizer Japan Inc.
-
Hamada Yoshimasa
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
TOMIZAWA KAORI
Pfizer WW Safety Sciences-Nagoya
-
YAMADA HIROSHI
Pfizer WW Safety Sciences-Nagoya
-
Horii Ikuo
Woldwide Safety Sciences Nagoya Laboratories Pfizer Inc.
-
Suzuki Koji
Department Of Applied Chemistry Faculty Of Science And Technology Keio University
-
Sawada Yasufusa
Pharmacokinetics Dynamics Metabolism Pfizer Global Research And Development Nagoya Laboratories Pfiz
-
Kato Masashi
Department Of Bioenvironmental Medline Chiba Univ.:center For Environment Health And Field Sciences
-
Suzuki Koji
Department Of Molecular Pathology Mei University School Of Medicine
-
Sato Yasushi
Drug Safety And Pharmacokinetics Laboratories Taisho Pharmaceutical Co. Ltd.
-
IWASAKI Kazuhide
Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd.
-
Wang Xusheng
PRESTO, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan
-
Yamada Hiroshi
PRESTO, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan
-
SUZUKI Koji
Department of Agricultural Chemistry, University of the Ryukyus
著作論文
- Development of in vitro 3T3 Cell Neutral Red Uptake Phototoxicity Screening System(Test methods, Proceedings of the 32nd Annual Meeting)
- CHANGES OF MICRO-RNA EXPRESSION IN RAT LIVER TREATED BY ACETAMINOPHEN OR CARBON TETRACHLORIDE : REGULATING ROLE OF MICRO-RNA FOR RNA EXPRESSION
- EVALUATION OF HUMAN HEPATOCYTE CHIMERIC MICE AS A MODEL FOR TOXICOLOGICAL INVESTIGATION USING PANOMIC APPROACHES : EFFECT OF ACETAMINOPHEN ON THE EXPRESSION PROFILES OF PROTEINS AND ENDOGENOUS METABOLITES IN LIVER, PLASMA AND URINE
- GENOMIC CLUSTER AND NETWORK ANALYSIS FOR PREDICTIVE SCREENING FOR HEPATOTOXICITY
- PHYSICOCHEMICAL AND CELL-BASED APPROACH FOR EARLY SCREENING OF PHOSPHOLIPIDOSIS-INDUCING POTENTIAL
- INVESTIGATION OF PROTEOMIC BIOMARKERS IN IN VIVO HEPATOTOXICITY STUDY OF RAT LIVER : TOXICITY DIFFERENTIATION IN HEPATOTOXICANTS
- IN VIVO HEPATOTOXICITY STUDY OF RATS IN COMPARISON WITH IN VITRO HEPATOTOXICITY SCREENING SYSTEM
- Introduction of the in vivo Mini-tox study as an effective tool to improve confidence in safety in the early stage of drug development (2) Effects of atypical antipsychotics X(Test methods, Proceedings of the 32nd Annual Meeting)
- Investigation of protein expression induced by hepatotoxicants in rat hepatocytes cultures and livers(Proceedings of the 32nd Annual Meeting)
- Changes of sperm functions and epididymal gene expression in the rats treated with sulfasalazine for several days(Development, Reproduction, Proceedings of the 32nd Annual Meeting)
- Effect of aging on QT interval in guinea pigs(Circulatory system, Proceedings of the 32nd Annual Meeting)
- PRACTICAL APPLICATION OF GUINEA PIG TELEMETRY SYSTEM FOR QT EVALUATION
- EFFECT OF AUTONOMIC NERVOUS FUNCTION ON QT INTERVAL IN DOGS
- IDENTIFICATION OF OXIDATIVE STRESS-RELATED PROTEINS FOR PREDICTIVE SCREENING OF HEPATOTOXICITY USING A PROTEOMIC APPROACH
- EFFECTS OF MALE REPRODUCTIVE TOXICANTS ON GENE EXPRESSION IN RAT TESTES
- PROTEIN EXPRESSION ANALYSIS OF RAT TESTES INDUCED TESTICULAR TOXICITY WITH SEVERAL REPRODUCTIVE TOXICANTS
- INVESTIGATION OF A HEPATOTOXICITY SCREENING SYSTEM IN PRIMARY CELL CULTURES : WHAT BIOMARKERS WOULD NEED TO BE ADDRESSED TO ESTIMATE TOXICITY IN CONVENTIONAL AND NEW APPROACHES?
- P8-45 Estimation of exposure in toxicology study in discovery stage(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P8-34 Usefulness of beam walking test for prediction of adverse effects, "vertigo and dizziness"(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- In Vitro Method Investigation for Drugs Induced Vasculitis Evaluation (CIRCULATORY SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Evaluation of the effects of Sulfasalazine, a male reproductive toxicant, on acrosome reaction in rat sperm.(GENERAL SESSION BY POSTER PRESENTATION)(DEVELOPMENT AND REPRODUCTION)
- P6-46 Effect of reproductive toxicants on the protein expression in the rat testis(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-45 Effect of reproductive toxicants on the gene expression in the testes of rats(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Effects of sulfasalazine on gene expressions in testis and epididymis (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- P7-61 Variation of neurotransmitter contents in the cerebrospinal fluid of conscious dogs(ENDOCRINE AND NERVOUS SYSTEM)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P7-58 Comparison of the chemicals on open-field activities in rats(ENDOCRINE AND NERVOUS SYSTEM)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Recovery of cardiovascular parameters in beagle dogs after excitement induced by human contact(Circulatory system, Proceedings of the 32nd Annual Meeting)
- P8-22 Effect of autonomic nervous activity on QT interval in dogs(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-14 Development of telemetry system for QT evaluation in guinea pigs(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Toxicomarker Discovery for Hepatotoxicity using Proteome Analysis Technology (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Usefulness of Teflon sonde for oral administration in rats (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Studies on AC Electroluminescence Device Made of BaTiO_3-CaTiO_3:Pr^ Diphase Ceramics
- Enhancement of Photoluminescence in CaTiO_3:Pr^ by Ba and Sr Substitution for Ca
- Synthesis and Electric Property of CeAlO_3 Ceramics
- P6-20 Usefulness of measuring QT interval with chest lead in Beagle Dogs(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P8-33 Validation of an in vitro screening assay for phospholipidosis in drug development(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- The use of gene expression profiling in rat hepatocyte cultures using adapter-tagged competitive PCR (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)